Publications

5808 Results

Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)

Authors
PJ Hesketh;K Chansky;DHM Lau;JH Doroshow;CM Moinpour;RA Chapman;JW Goodwin;HM Gross;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(6):537-544
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0027

Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group study 9024

Authors
GP Swanson;J Faulkner;SR Smalley;MJ Noble;RL Stephens;TJ O'Rourke;GR Weiss;DP Quick;IM Thompson, Jr;ED Crawford
Journal / Conference
Journal of Urology 176:548-553
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9024

Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group study S0126

Authors
HL West;WA Franklin;J McCoy;P Gumerlock;R Vance;DHM Lau;K Chansky;JJ Crowley;DR Gandara
Journal / Conference
Journal of Clinical Oncology 24(12):1807-1813
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0126

Concurrent chemotherapy plus cetuximab or chemotherapy followed by cetuximab in advanced non-small cell lung cancer (NSCLC): a randomized phase II selectional trial SWOG 0342

Authors
K Kelly;RS Herbst;JJ Crowley;J McCoy;JN Atkins;PN Lara;SR Dakhil;KS Albain;ES Kim;DR Gandara
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7015
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0342

MGMT methylation in newly-diagnosed glioblastoma multiforme (GBM): from the S0001 phase III study of radiation therapy (RT) and O-benzylguanine, (O BG) plus BCNU versus RT and BCNU alone for newly diagnosed GBM.

Authors
DT Blumenthal;M Wade;C Rankin;F Fitzpatrick;K Stelzer;A Sloan;W Ackerley;EJ Rushing
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#1512
Year
2006
Research Committee(s)
Brain
Study Number(s)
S0001

Alternative measures predicting clinical benefit in advanced non-small cell lung cancer (NSCLC) from Southwest Oncology Group (SWOG) randomized trials: implications for clincial trial design

Authors
PN Lara;MW Redman;K Kelly;MJ Edelman;SK Williamson;JJ Crowley;DR Gandara
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7006
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0003, SWOG-9509, S9806

SWOG 0012, a randomized phase III comparison of standard doxorubicin (A) and cyclophosphamide (C) followed by weekly paclitaxel (T) versus weekly doxorubicin and daily oral cyclophosphamide plus G-CSF (G) followed by weekly paclitaxel as neoadjuvant therapy for inflammatory and locally advanced breast cancer

Authors
GK Ellis;SJ Green;CA Russell;ME Royce;EA Perez;RB Livingston
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#LBA537
Year
2006
Research Committee(s)
Breast
Study Number(s)
S0012

SWOG 0338: a phase II trial of imatinib mesylate in combination with capecitabine in metastatic breast cancer.

Authors
H Chew;B Barlow;K Albain;D Lew;GT Budd;A Gown;J Gralow;RB Livingston
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#10529
Year
2006
Research Committee(s)
Breast
Study Number(s)
S0338

Sorafenib plus interferon-a2b (IFN) as first-line therapy for advanced renal cell carcinoma (RCC): SWOG 0412

Authors
CW Ryan;B Goldman;PN Lara;TM Beer;HA Drabkin;ED Crawford
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#4525
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S0412

Surgical resection for stage IV melanoma: a Southwest Oncology Group trial (S9430)

Authors
VK Sondak;PY Liu;J Warneke;J Vetto;R Tuthill;B Redman;JA Sosman
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#8019
Year
2006
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9430